The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Digital Edition Archives Authors Reviewers

Page 100

More JCP Articles

JCP
Original Research

October 15, 2019

This study aimed to estimate the prevalence of metabolic syndrome and its components in patients with treatment-resistant depression and determine correlations with sociodemographic, clinical, and treatment-related factors—read the article…
, , , et al
JCP
Original Research

October 15, 2019

Sex-specific differences occur in several aspects of schizophrenia, though sex differences in comorbid depressive symptoms have not specifically been reported. This study examined sex differences in depressive symptoms in…
, , , et al
JCP
Review Article

October 8, 2019

Depression can cause notable cognitive deficits. Read this review article to learn about the efficacy of the wakefulness-promoting drug modafinil in the treatment of cognitive impairments associated with major…
, , , et al
JCP
Original Research

October 1, 2019

Adjunctive atypical antipsychotics can increase antidepressant response in depressed patients, but may cause adverse metabolic effects. This study examines the metabolic effects of adjunctive brexpiprazole in patients with major…
, , , et al
JCP
Clinical and Practical Psychopharmacology

October 1, 2019

Does benzodiazepine use during pregnancy increase the risk of major malformations? In this article, Dr Andrade takes a close look at the methodology of a recent meta-analysis and proposes…
JCP
Original Research

September 24, 2019

The use of atypical antipsychotics as adjunctive treatment for nonresponsive depression is limited by their side effects. This study explores whether pimavanserin can be both an efficacious and tolerable…
, , , et al
JCP
Clinical and Practical Psychopharmacology

September 24, 2019

Do benzodiazepines pose a risk when taken during pregnancy? A recent case-control study indicated nearly doubled odds of spontaneous abortion. Dr Andrade takes a closer look at this study…
JCP
Original Research

September 24, 2019

Clozapine is the only medication approved for refractory schizophrenia, yet it is underused. Further, for minimal response to clozapine treatment, there is little guidance on the next step. Here,…
, , , et al
JCP
Educational Activity

September 24, 2019

In a series of brief video segments, experts in neurology, psychiatry, and primary care discuss the diagnosis and treatment of Alzheimer’s disease.
, ,
JCP
In Memoriam

September 17, 2019

A reflection on the legacy and contributions of Donald F. Klein, a founding member of ASCP and pioneer in the modern era of psychiatry.
,
JCP
Academic Highlights

September 17, 2019

Long-acting injectable antipsychotics can be a powerful strategy in helping patients to receive ongoing benefit from treatment. You might think that you have adequately explained this treatment option to…
,
JCP
Original Research

September 17, 2019

Do certain aspects of a patient’s stay in and discharge from a psychiatric hospital predict their subsequent risk for suicide? This case-control study looked for clues in order to…
, , , et al

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe